Skip to main content
SpringerLink
Log in

Diabetic Peripheral Neuropathy

  • Chapter
Book cover Obesity and Diabetes

Part of the book series: Contemporary Diabetes ((CDI))

  • 2309 Accesses

Abstract

Diabetic peripheral neuropathy is the most prevalent peripheral neuropathy in the Western world. It has been reported to affect nearly 50% of people with diabetes (1,2). It is responsible for a significant proportion of the mortality and morbidity that accompany diabetes and ranks third in lifetime expenditures associated with diabetic complications (3). Diabetic peripheral neuropathy was until recently thought to be a late complication of diabetes; however, there is growing evidence that neuropathy may be associated with glucose intolerance and may even be the presenting symptom of diabetes (4–6). Diabetes affects the peripheral nervous system in at least four distinctive patterns (see Table 1). Chronic, distal sensory-motor polyneuropathy, referred to as diabetic neuropathy, is the most common. However, there are acute forms of diabetic neuropathy and various focal syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) [in French]. Diabetes Metab 1977;3(4):245–256.

    CAS  Google Scholar 

  2. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study [published erratum appears in Neurology 1993;43(11):2345]. Neurology 1993;43(4):817–824.

    PubMed  CAS  Google Scholar 

  3. Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the US Diabetes Care 2002;25(3):476–481.

    Google Scholar 

  4. Russell JW, Feldman EL. Impaired glucose tolerance—does it cause neuropathy? Muscle Nerve 2001;24(9):1109–1112.

    Article  PubMed  CAS  Google Scholar 

  5. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001;24(8):1448–1453.

    Article  PubMed  CAS  Google Scholar 

  6. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001;24(9):1229–1231.

    Article  PubMed  CAS  Google Scholar 

  7. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333(2):89–94.

    Article  PubMed  CAS  Google Scholar 

  8. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39(11):1377–1384.

    Article  PubMed  CAS  Google Scholar 

  9. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38(11):1456–1461.

    Article  PubMed  CAS  Google Scholar 

  10. Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999;22(9):1479–1486.

    Article  PubMed  CAS  Google Scholar 

  11. Straub RH, Thum M, Hollerbach C, et al. Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care 1994;17(11):1290–1294.

    Article  PubMed  CAS  Google Scholar 

  12. Edmonds ME. The diabetic foot: pathophysiology and treatment. Clin Endocrinol Metab 1986;15:889–916.

    PubMed  CAS  Google Scholar 

  13. Boulton AJ. The pathogenesis of diabetic foot problems: an overview [review]. Diabet Med 1996;13(Suppl 1):S12–S16.

    PubMed  Google Scholar 

  14. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med 1996;13(Suppl 1):S6–S11.

    PubMed  Google Scholar 

  15. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22(1):157–162.

    Article  PubMed  CAS  Google Scholar 

  16. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26(5):1553–1579.

    Article  PubMed  Google Scholar 

  17. Stewart JD, McKelvey R, Durcan L, et al. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Sci 1996;142(1–2):59–64.

    Article  PubMed  CAS  Google Scholar 

  18. Gorson KC, Ropper AH, Adelman LS, Weinberg DH. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2000;23(1):37–43.

    Article  PubMed  CAS  Google Scholar 

  19. Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003;27(4):465–470.

    Article  PubMed  Google Scholar 

  20. Sharma KR, Cross J, Farronay O, et al. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 2002;59(5):758–765.

    Article  PubMed  Google Scholar 

  21. Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group [see comments]. N Engl J Med 1993;329:977–986.

    Google Scholar 

  22. Morley GK, Mooradian AD, Levine AS, Morley JE. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med 1984;77(1):79–82.

    Article  PubMed  CAS  Google Scholar 

  23. Greene DA, Lattimer SA, Sima AA. Sorbitol phosphinositides, and sodium-potassium ATPase in pathogenesis of diabetic complications. N Engl J Med 1978;316:599–606.

    Google Scholar 

  24. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992;15(12):1835–1843.

    Article  PubMed  CAS  Google Scholar 

  25. Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review [see comments]. J Neuropathol Exp Neurol 1996;55(12):1181–1193.

    Article  PubMed  CAS  Google Scholar 

  26. Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 2002;288(20):2579–2588.

    Article  PubMed  CAS  Google Scholar 

  27. Dyck PJ, Karnes JL, O’Brien P, et al. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986;19:440–449.

    Article  PubMed  CAS  Google Scholar 

  28. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997;46(Suppl 2):S38–S42.

    PubMed  CAS  Google Scholar 

  29. Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003;111(4):431–433.

    Article  PubMed  CAS  Google Scholar 

  30. Du X, Matsumura T, Edelstein D, et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 2003;112(7):1049–1057.

    Article  PubMed  CAS  Google Scholar 

  31. Obrosova IG, Li F, Abatan OI, et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 2004;53(3):711–720.

    Article  PubMed  CAS  Google Scholar 

  32. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 2004;9(1):26–53.

    Article  PubMed  CAS  Google Scholar 

  33. Younger DS, Rosoklija G, Hays AP, et al. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve 1996;19(6):722–727.

    Article  PubMed  CAS  Google Scholar 

  34. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001;24(9):1225–1228.

    Article  PubMed  CAS  Google Scholar 

  35. Smith AG, Ramachandran P, Tripp S, Singleton JR. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001;57(9):1701–1704.

    PubMed  CAS  Google Scholar 

  36. Sumner CJ, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003;60(1):108–111.

    PubMed  CAS  Google Scholar 

  37. Anonymous. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995;122(8):561–568.

    Google Scholar 

  38. Periquet MI, Novak V, Collins MP, et al. Painful sensory neuropathy: prospective evaluation using skin biopsy [see comments]. Neurology 1999;53(8):1641–1647.

    PubMed  CAS  Google Scholar 

  39. Jeppesen U, Gaist D, Smith T, Sindrup SH. Statins and peripheral neuropathy. Eur J Clin Pharmacol 1999;54(11):835–838.

    Article  PubMed  CAS  Google Scholar 

  40. Feldman EL, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17(11):1281–1289.

    Article  PubMed  CAS  Google Scholar 

  41. Gruener G, Dyck PJ. Quantitative sensory testing: methodology, applications, and future directions [review]. J Clin Neurophysiol 1994;11(6):568–583.

    Article  PubMed  CAS  Google Scholar 

  42. Stewart JD, Freeman R. Quantitative sensory testing. In: Brown WF, Bolton CF, Aminoff MJ, eds. Neuromuscular Function and Disease. WB Saunders, Philadelphia, 2002, pp. 131–144.

    Google Scholar 

  43. Freeman R. The peripheral nervous system and diabetes. In: Kahn CR, Weir GC, King GL, eds. Joslin’s Diabetes Mellitus. Lippincott Williams & Wilkins, Philadelphia, 2002.

    Google Scholar 

  44. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 yr experience in diabetes. Diabetes Care 1985;8:491–498.

    Article  PubMed  CAS  Google Scholar 

  45. Ziegler D, Dannehl K, Muhlen H, et al. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 1992;9(9):806–814.

    PubMed  CAS  Google Scholar 

  46. Sima AA, Brown MB, Prashar A, et al. The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy. Diabetologia 1992;35(6):560–569.

    Article  PubMed  CAS  Google Scholar 

  47. McArthur JC, Stocks EA, Hauer P, et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency [see comments]. Arch Neurol 1998;55(12):1513–1520.

    Article  PubMed  CAS  Google Scholar 

  48. Herrmann DN, Griffin JW, Hauer P, et al. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999;53(8):1634–1640.

    PubMed  CAS  Google Scholar 

  49. Anonymous. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998;41(4):416–423.

    Google Scholar 

  50. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-yr study [see comments]. Diabetes Res Clin Pract 1995;28(2):103–117.

    Article  PubMed  CAS  Google Scholar 

  51. Reichard P, Britz A, Carlsson P, et al. Metabolic control and complications over 3 yr in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS). J Intern Med 1990;228(5):511–517.

    PubMed  CAS  Google Scholar 

  52. Reichard P, Berglund B, Britz A, et al. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 yr. J Intern Med 1991;230:101–108.

    PubMed  CAS  Google Scholar 

  53. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus [see comments]. N Engl J Med 1993;329(5):304–309.

    Article  PubMed  CAS  Google Scholar 

  54. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study [see comments]. Lancet 1999;353(9153):617–622.

    Article  PubMed  CAS  Google Scholar 

  55. Anonymous. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38(6):869–880.

    Google Scholar 

  56. Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic neuropathy [see comments]. N Engl J Med 1990;322:1031–1037.

    Article  PubMed  CAS  Google Scholar 

  57. Navarro X, Kennedy WR, Loewenson RB, Sutherland DE. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990;39:802–806.

    Article  PubMed  CAS  Google Scholar 

  58. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy [see comments]. Ann Neurol 1997;42(5):727–736.

    Article  PubMed  CAS  Google Scholar 

  59. Nusser J, Scheuer R, Abendroth D, et al. Effect of pancreatic and/or renal transplantation on diabetic autonomic neuropathy. Diabetologia 1991;34(Suppl 1):S118–S120.

    Article  PubMed  Google Scholar 

  60. Solders G, Wilczek H, Gunnarsson R, et al. Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-yr follow-up study. Lancet 1987;2:1232–1235.

    Article  PubMed  CAS  Google Scholar 

  61. Solders G, Tyden G, Persson A, Groth CG. Improvement in diabetic neuropathy 4 yr after successful pancreatic and renal transplantation. Diabetologia 1991;34(Suppl 1):S125–S127.

    Article  PubMed  Google Scholar 

  62. Trojaborg W, Smith T, Jakobsen J, Rasmussen K. Effect of pancreas and kidney transplantation on the neuropathic profile in insulin-dependent diabetics with end-stage nephropathy. Acta Neurol Scand 1994;90(1):5–9.

    Article  PubMed  CAS  Google Scholar 

  63. Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. JAMA 2000;284(17):2215–2221.

    Article  PubMed  CAS  Google Scholar 

  64. Jamal GA, Carmichael H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet Med 1990;7(4):319–323.

    Article  PubMed  CAS  Google Scholar 

  65. Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group [see comments]. Diabetes Care 1993;16(1):8–15.

    Article  PubMed  CAS  Google Scholar 

  66. Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003;26(3):770–776.

    Article  PubMed  CAS  Google Scholar 

  67. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004;21(2):114–121.

    Article  PubMed  CAS  Google Scholar 

  68. Tutuncu NB, Bayraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care 1998;21(11):1915–1918.

    Article  PubMed  CAS  Google Scholar 

  69. Llewelyn JG, Gilbey SG, Thomas PK, et al. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy: a clinicopathological study. Brain 1991;114:867–892.

    Article  PubMed  Google Scholar 

  70. Malik RA. The pathology of human diabetic neuropathy. Diabetes 1997;46(Suppl 2):S50–S53.

    PubMed  CAS  Google Scholar 

  71. Oyibo SO, Prasad YD, Jackson NJ, et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002;19(10):870–873.

    Article  PubMed  CAS  Google Scholar 

  72. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55(7):915–920.

    PubMed  CAS  Google Scholar 

  73. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326(19):1250–1256.

    Article  PubMed  CAS  Google Scholar 

  74. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135–144.

    Article  PubMed  CAS  Google Scholar 

  75. Sindrup SH, Bach FW, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003;60(8):1284–1289.

    PubMed  CAS  Google Scholar 

  76. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977;22(2):196–199.

    PubMed  CAS  Google Scholar 

  77. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial [see comments]. JAMA 1998;280(21):1831–1836.

    Article  PubMed  CAS  Google Scholar 

  78. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004;110(3):628–638.

    Article  PubMed  CAS  Google Scholar 

  79. McCleane GJ. Lamotrigine in the management of neuropathic pain: a review of the literature. Clin J Pain 2000;16(4):321–326.

    Article  PubMed  CAS  Google Scholar 

  80. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57(3):505–509.

    PubMed  CAS  Google Scholar 

  81. Harati Y, Gooch C, Swenson M, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 2000;14(2):65–70.

    Article  PubMed  CAS  Google Scholar 

  82. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003;60(6):927–934.

    PubMed  CAS  Google Scholar 

  83. Saenz de Tejada I, Anglin G, Knight JR, Emmick JT. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 2002;25(12):2159–2164.

    Article  Google Scholar 

  84. Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003;26(3):777–783.

    Article  PubMed  CAS  Google Scholar 

  85. Shaw JE, Abbott CA, Tindle K, et al. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia 1997;40(3):299–301.

    Article  PubMed  CAS  Google Scholar 

  86. Restivo DA, Lanza S, Patti F, et al. Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A. Neurology 2002;59(12):1971–1973.

    Article  PubMed  CAS  Google Scholar 

  87. Archer AG, Watkins PJ, Thomas PK, et al. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983;46(6):491–499.

    PubMed  CAS  Google Scholar 

  88. Caravati CM. Insulin neuritis: a case report. Va Med Monthly 1933;59:745, 746.

    Google Scholar 

  89. Ellenberg M. Diabetic neuropathy precipitating after institution of diabetic control. Am J Med Sci 1958;236:466.

    PubMed  CAS  Google Scholar 

  90. Llewelyn JG, Thomas PK, Fonseca V, et al. Acute painful diabetic neuropathy precipitated by strict glycemic control. Acta Neuropathol (Berl) 1986;72:157–163.

    Article  CAS  Google Scholar 

  91. Said G, Goulon-Goeau C, Slama G, Tchobroutsky G. Severe early-onset polyneuropathy in insulindependent diabetes mellitus. A clinical and pathological study. N Engl J Med 1992;326:1257–1263.

    Article  PubMed  CAS  Google Scholar 

  92. Thomas PK. Diabetic neuropathy: mechanisms and future treatment options. J Neurol Neurosurg Psychiatry 1999;67(3):277–279.

    PubMed  CAS  Google Scholar 

  93. Bastron JA, Thomas JE. Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients. Mayo Clin Proc 1981;56(12):725–732.

    PubMed  CAS  Google Scholar 

  94. Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999;53(9):2113–2121.

    PubMed  CAS  Google Scholar 

  95. Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 yr later. Arch Neurol 1991;48(11):1130–1135.

    PubMed  CAS  Google Scholar 

  96. Said G, Elgrably F, Lacroix C, et al. Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome. Ann Neurol 1997;41(6):762–770.

    Article  PubMed  CAS  Google Scholar 

  97. Coppack SW, Watkins PJ. The natural history of diabetic femoral neuropathy [see comments]. Q J Med 1991;79(288):307–313.

    PubMed  CAS  Google Scholar 

  98. Chokroverty S. Proximal nerve dysfunction in diabetic proximal amyotrophy: electrophysiology and electron microscopy. Arch Neurol 1982;39(7):403–407.

    PubMed  CAS  Google Scholar 

  99. Chokroverty S. AAEE case report 13: diabetic amyotrophy. Muscle Nerve 1987;10(8):679–684.

    Article  PubMed  CAS  Google Scholar 

  100. Chokroverty S, Sander HW. AAEM case report 13: diabetic amyotrophy [published erratum appears in Muscle Nerve 1996;19(12):1655]. Muscle Nerve 1996;19(8):939–945.

    Article  PubMed  CAS  Google Scholar 

  101. Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc 1997;72(12):1123–1132.

    PubMed  CAS  Google Scholar 

  102. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;35(5):559–569.

    Article  PubMed  CAS  Google Scholar 

  103. Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus [see comments]. Arch Neurol 1995;52(11):1053–1061.

    PubMed  CAS  Google Scholar 

  104. Hamilton CR Jr, Dobson HL, Marshall J. Diabetic amyotrophy: clinical and electronmicroscopic studies in six patients. Am J Med Sci 1968;256(2):81–90.

    Article  PubMed  Google Scholar 

  105. Casey EB, Harrison MJ. Diabetic amyotrophy: a follow-up study. BMJ 1972;1(801):656–659.

    PubMed  CAS  Google Scholar 

  106. Lauria G, McArthur JC, Hauer PE, et al. Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J Neurol Neurosurg Psychiatry 1998;65(5):762–766.

    Article  PubMed  CAS  Google Scholar 

  107. Stewart JD. Diabetic truncal neuropathy: topography of the sensory deficit. Ann Neurol 1989;25(3):233–238.

    Article  PubMed  CAS  Google Scholar 

  108. Sun SF, Streib EW. Diabetic thoracoabdominal neuropathy: clinical and electrodiagnostic features. Ann Neurol 1981;9(1):75–79.

    Article  PubMed  CAS  Google Scholar 

  109. Kikta DG, Breuer AC, Wilbourn AJ. Thoracic root pain in diabetes: the spectrum of clinical and electromyographic findings. Ann Neurol 1982;11(1):80–85.

    Article  PubMed  CAS  Google Scholar 

  110. Fraser DM, Campbell IW, Ewing DJ, Clarke BF. Mononeuropathy in diabetes mellitus. Diabetes 1979;28:96–101.

    Article  PubMed  CAS  Google Scholar 

  111. Mulder DW, Lambert EH, Bastron JA, Sprague RG. The neuropathies associated with diabetes mellitus: a clinical and electromyographic study of 103 unselected diabetic patients. Neurology 1961;11(4)(Pt 1):275–284.

    Article  PubMed  Google Scholar 

  112. Albers JW, Brown MB, Sima AA, Greene DA. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Tolrestat Study Group for Edit (Early Diabetes Intervention Trial). Muscle Nerve 1996;19(2):140–146.

    Article  PubMed  CAS  Google Scholar 

  113. Nathan PA, Keniston RC, Myers LD, Meadows KD. Obesity as a risk factor for slowing of sensory conduction of the median nerve in industry: a cross-sectional and longitudinal study involving 429 workers. J Occup Med 1992;34(4):379–383.

    PubMed  CAS  Google Scholar 

  114. de Carvalho MA, Matias T, Evangelista T, et al. Bilateral phrenic nerve neuropathy in a diabetic patient. Eur J Neurol 1996;3:481–482.

    Google Scholar 

  115. Zorrilla E, Kozak GP. Ophthalmoplegia in diabetes mellitus. Arch Intern Med 1967;67:968–976.

    CAS  Google Scholar 

  116. Ross AT. Recurrent cranial nerve palsies in diabetes mellitus. Neurology 1962;12:180–185.

    PubMed  CAS  Google Scholar 

  117. Jacobson DM. Relative pupil-sparing third nerve palsy: etiology and clinical variables predictive of a mass. Neurology 2001;56(6):797, 798.

    PubMed  CAS  Google Scholar 

  118. Breen LA, Hopf HC, Farris BK, Gutmann L. Pupil-sparing oculomotor nerve palsy due to midbrain infarction [see comments]. Arch Neurol 1991;48(1):105, 106.

    PubMed  CAS  Google Scholar 

  119. Richards BW, Jones FR Jr, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol 1992;113(5):489–496.

    PubMed  CAS  Google Scholar 

  120. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 1960;64:592–600.

    PubMed  CAS  Google Scholar 

  121. Korczyn AD. Bell’s palsy and diabetes mellitus. Lancet 1971;1(7690):108, 109.

    Article  PubMed  CAS  Google Scholar 

  122. Aminoff MJ, Miller AL. The prevalence of diabetes mellitus in patients with Bell’s palsy. Acta Neurol Scand 1972;48(3):381–384.

    PubMed  CAS  Google Scholar 

  123. Pecket P, Schattner A. Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy? J Neurol Neurosurg Psychiatry 1982;45(7):652–655.

    PubMed  CAS  Google Scholar 

  124. Adour KK, Wingerd J. Idiopathic facial paralysis (Bell’s palsy): factors affecting severity and outcome in 446 patients. Neurology 1974;24(12):1112–1116.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Rachel Nardin MD & Roy Freeman MD

Authors
  1. Rachel Nardin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roy Freeman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes & Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Christos S. Mantzoros MD, DSc

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Nardin, R., Freeman, R. (2006). Diabetic Peripheral Neuropathy. In: Mantzoros, C.S. (eds) Obesity and Diabetes. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-59259-985-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-985-1_19

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-538-5

  • Online ISBN: 978-1-59259-985-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation